Article Details

Novel Cancer Cachexia Drug FL-501 Shows 3X Better Half-Life in Preclinical Data

Retrieved on: 2025-04-25 20:02:25

Tags for this article:

Click the tags to see associated articles and topics

Novel Cancer Cachexia Drug FL-501 Shows 3X Better Half-Life in Preclinical Data. View article details on hiswai:

Excerpt

FL-501 is a potential best-in-class monoclonal antibody targeting growth differentiation factor 15 (GDF-15), a cytokine that is implicated in multiple ...

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo